4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-24-049079
Chief Financial Officer bought 2,907.2 shares at $7.36 ($21,397)
From the SEC's structured data for this filing
Trades in this filing
Pamir Ozan · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-22 | Purchase : show line 1 in the form | +2,907.2 | $7.36 | $21,397 | 2,907.2 | D |
| Open-market purchases · 2,907.2 sh · avg $7.36 · $21,397 | ||||||
Loading xslF345X05/wk-form4_1732537730.xml…